Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine.
暂无分享,去创建一个
[1] Laura Sciacca,et al. Diabetes and cancer. , 2009, Endocrine-related cancer.
[2] M. Maffei,et al. Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.
[3] P. Brennan,et al. The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study , 2017, Journal of the National Cancer Institute.
[4] E. Riboli,et al. Association of CRP genetic variants with blood concentrations of C‐reactive protein and colorectal cancer risk , 2015, International journal of cancer.
[5] F. Farzadfar,et al. Obesity-Related Metabolomic Profiles and Discrimination of Metabolically Unhealthy Obesity. , 2018, Journal of proteome research.
[6] D. Dunger,et al. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study , 2002, The Lancet.
[7] H. Senn,et al. Insulin-like growth factors and cancer. , 2002, The Lancet. Oncology.
[8] J. Danesh,et al. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data , 2011, BMJ : British Medical Journal.
[9] J. H. Lee,et al. Emerging clinical and experimental evidence for the role of lipocalin‐2 in metabolic syndrome , 2012, Clinical and experimental pharmacology & physiology.
[10] J. Escobar,et al. Gut microbiota is associated with obesity and cardiometabolic disease in a population in the midst of Westernization , 2018, Scientific Reports.
[11] F. Clavel-Chapelon,et al. Serum levels of IGF‐I, IGFBP‐3 and colorectal cancer risk: results from the EPIC cohort, plus a meta‐analysis of prospective studies , 2010, International journal of cancer.
[12] W. James,et al. Effect of Plain Versus Sugar‐Sweetened Breakfast on Energy Balance and Metabolic Health: A Randomized Crossover Trial , 2020, Obesity.
[13] T. Funahashi,et al. Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy. , 2003, The Journal of clinical endocrinology and metabolism.
[14] D. Hadrich. Microbiome Research Is Becoming the Key to Better Understanding Health and Nutrition , 2018, Front. Genet..
[15] C. Bogardus,et al. Plasma adiponectin and endogenous glucose production in humans. , 2003, Diabetes care.
[16] K. Matsuo,et al. Association between variations in the fat mass and obesity-associated gene and pancreatic cancer risk: a case–control study in Japan , 2013, BMC Cancer.
[17] J. Danesh,et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis , 2010, The Lancet.
[18] J. Kuk,et al. Changes in fat and skeletal muscle with exercise training in obese adolescents: comparison of whole-body MRI and dual energy X-ray absorptiometry , 2013, Obesity.
[19] Gretchen A. Stevens,et al. The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis , 2013, PloS one.
[20] D. Siscovick,et al. Plasma Fatty Acid–Binding Protein 4, Nonesterified Fatty Acids, and Incident Diabetes in Older Adults , 2012, Diabetes Care.
[21] Patel J Ashwin,et al. Leptin and the cardiovascular system: a review. , 2007, Recent patents on cardiovascular drug discovery.
[22] P. Visscher,et al. Meta-analysis of genome-wide association studies for height and body mass index in ∼700,000 individuals of European ancestry , 2018, bioRxiv.
[23] E. Riboli,et al. Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden) , 2002, Cancer Causes & Control.
[24] M. Czech. Insulin action and resistance in obesity and type 2 diabetes , 2017, Nature Medicine.
[25] M. Copetti,et al. Association between Resistin Levels and All-Cause and Cardiovascular Mortality: A New Study and a Systematic Review and Meta-Analysis , 2015, PloS one.
[26] Diana van Heemst,et al. Insulin, IGF-1 and longevity. , 2010, Aging and disease.
[27] J. Albu,et al. Lifestyle, anthropometric, and obesity-related physiologic determinants of insulin-like growth factor-1 in the Third National Health and Nutrition Examination Survey (1988-1994). , 2010, Annals of epidemiology.
[28] M. Pollak,et al. Insulin-like Growth Factors and Prostate Cancer , 2001, Cancer and Metastasis Reviews.
[29] Gary L Myers,et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.
[30] R. Collins,et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies , 2009, Lancet.
[31] Lei Wu,et al. Leptin Receptor Gene Polymorphism and the Risk of Cardiovascular Disease: A Systemic Review and Meta-Analysis , 2017, International journal of environmental research and public health.
[32] D. Mozaffarian,et al. Fatty acid‐binding protein 4 and incident heart failure: the Cardiovascular Health Study , 2013, European journal of heart failure.
[33] Y. Song,et al. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone , 1997, International Journal of Obesity.
[34] T. Pischon. Use of Obesity Biomarkers in Cardiovascular Epidemiology , 2009, Disease markers.
[35] V. Macaulay,et al. Insulin-like growth factors and cancer. , 1992, British Journal of Cancer.
[36] P. Libby,et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.
[37] G. Shulman,et al. Downregulation of ADIPOQ and PPARγ2 Gene Expression in Subcutaneous Adipose Tissue of Obese Adolescents With Hepatic Steatosis , 2010, Obesity.
[38] J. Sethi,et al. Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine , 2016, British journal of pharmacology.
[39] Shuijun Zhang,et al. Leptin concentration and risk of coronary heart disease and stroke: A systematic review and meta-analysis , 2017, PloS one.
[40] N. Kalupahana,et al. Immunity as a link between obesity and insulin resistance. , 2012, Molecular aspects of medicine.
[41] A. Engin. Diet-Induced Obesity and the Mechanism of Leptin Resistance. , 2017, Advances in experimental medicine and biology.
[42] B. Koletzko,et al. Metabolomic Biomarkers for Obesity in Humans: A Short Review , 2014, Annals of Nutrition and Metabolism.
[43] M. Schulze,et al. General and abdominal adiposity and risk of death in Europe. , 2008, The New England journal of medicine.
[44] M. Aboul-Ela,et al. Role of community pharmacists in weight management: results of a national study in Lebanon , 2020, BMC Health Services Research.
[45] E. Carlsson,et al. A polymorphism in the adiponectin gene influences adiponectin expression levels in visceral fat in obese subjects , 2006, International Journal of Obesity.
[46] Jon White,et al. Role of Adiponectin in Coronary Heart Disease Risk , 2016, Circulation research.
[47] Herbert Tilg,et al. Adipocytokines: mediators linking adipose tissue, inflammation and immunity , 2006, Nature Reviews Immunology.
[48] R. Gomis,et al. Proteomics in obesity research , 2009, Proteomics. Clinical applications.
[49] H. Park,et al. Relationship between vaspin gene expression and abdominal fat distribution of Korean women. , 2011, Endocrine journal.
[50] Joel Kullberg,et al. Measurements of total and regional body composition in preschool children: A comparison of MRI, DXA, and anthropometric data , 2013, Obesity.
[51] V. Montori,et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis , 2010, International Journal of Obesity.
[52] K. Thankappan,et al. Obesity indicators that best predict type 2 diabetes in an Indian population: insights from the Kerala Diabetes Prevention Program , 2020, Journal of nutritional science.
[53] T. Liou,et al. ESR1, FTO, and UCP2 Genes Interact with Bariatric Surgery Affecting Weight Loss and Glycemic Control in Severely Obese Patients , 2011, Obesity surgery.
[54] P. Sham,et al. Circulating Adipocyte-Fatty Acid Binding Protein Levels Predict the Development of the Metabolic Syndrome: A 5-Year Prospective Study , 2007, Circulation.
[55] Tie-Lin Yang,et al. Gene expression profiles indicate tissue-specific obesity regulation changes and strong obesity relevant tissues , 2018, International Journal of Obesity.
[56] H. Schiöth,et al. A Genetic Risk Score Is Associated with Weight Loss Following Roux-en Y Gastric Bypass Surgery , 2016, Obesity Surgery.
[57] M. Jarvelin,et al. A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.
[58] Tamara S. Roman,et al. New genetic loci link adipose and insulin biology to body fat distribution , 2014, Nature.
[59] Aung Ko Win,et al. Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[60] C. Dive,et al. Biological mechanisms linking obesity and cancer risk: new perspectives. , 2010, Annual review of medicine.
[61] Qianchuan He,et al. Fasting insulin concentrations and incidence of hypertension, stroke, and coronary heart disease: a meta-analysis of prospective cohort studies. , 2013, The American journal of clinical nutrition.
[62] J. M. Goodson,et al. A Data Mining Approach Identified Salivary Biomarkers That Discriminate between Two Obesity Measures , 2019, Journal of obesity.
[63] Serum resistin is causally related to mortality risk in patients with type 2 diabetes: preliminary evidences from genetic data , 2017, Scientific Reports.
[64] Tracey H. Taveira,et al. Fasting Serum C‐Peptide Levels Predict Cardiovascular and Overall Death in Nondiabetic Adults , 2012, Journal of the American Heart Association.
[65] E. Giovannucci,et al. Plasma Adiponectin and Soluble Leptin Receptor and Risk of Colorectal Cancer: A Prospective Study , 2013, Cancer Prevention Research.
[66] S. Kahn,et al. Mechanisms linking obesity to insulin resistance and type 2 diabetes , 2006, Nature.
[67] P. Pisani. Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies , 2008, Archives of physiology and biochemistry.
[68] T. Key,et al. Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women , 2003, Cancer Causes & Control.
[69] F. Friedenberg,et al. Genetic Associations of Obesity: The Fat-Mass and Obesity-Associated (FTO) Gene , 2016, Clinical and Translational Gastroenterology.
[70] J. Manson,et al. Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts , 2007, British Journal of Cancer.
[71] Q. Yao,et al. Resistin: functional roles and therapeutic considerations for cardiovascular disease , 2012, British journal of pharmacology.
[72] H. Brenner,et al. Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: meta-analysis of individual participant data of seven prospective cohorts in Europe , 2017, British Journal of Cancer.
[73] T. Pischon,et al. Body fatness, related biomarkers and cancer risk: an epidemiological perspective , 2015, Hormone molecular biology and clinical investigation.
[74] G. Franco,et al. A single FTO gene variant rs9939609 is associated with body weight evolution in a multiethnic extremely obese population that underwent bariatric surgery. , 2015, Nutrition.
[75] J. Pankow,et al. Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study , 2013, Cancer Causes and Control.
[76] Kyoung-Bok Min,et al. Serum C-peptide levels and risk of death among adults without diabetes mellitus , 2013, Canadian Medical Association Journal.
[77] M. Zwahlen,et al. Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality. , 2011, The Journal of clinical endocrinology and metabolism.
[78] F. Clavel-Chapelon,et al. Adiposity, mediating biomarkers and risk of colon cancer in the European prospective investigation into cancer and nutrition study , 2014, International journal of cancer.
[79] T. Pischon,et al. Body mass index, waist circumference, and the risk of type 2 diabetes mellitus: implications for routine clinical practice. , 2010, Deutsches Arzteblatt international.
[80] A. Rissanen,et al. Acquired obesity increases CD68 and tumor necrosis factor-alpha and decreases adiponectin gene expression in adipose tissue: a study in monozygotic twins. , 2006, The Journal of clinical endocrinology and metabolism.
[81] S. Bojesen,et al. Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[82] Helen E. Parkinson,et al. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog) , 2016, Nucleic Acids Res..
[83] L. Coussens,et al. Inflammation and cancer , 2002, Nature.
[84] Mark Woodward,et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. , 2011, Lancet.
[85] M. Fasshauer,et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. , 2005, Diabetes.
[86] S. Parlee,et al. Chemerin: a potential endocrine link between obesity and type 2 diabetes , 2012, Endocrine.
[87] T. Erlinger,et al. C‐reactive protein and colorectal cancer risk: A systematic review of prospective studies , 2008, International journal of cancer.
[88] G. Steinberg,et al. Adipose tissue as an endocrine organ , 2010, Molecular and Cellular Endocrinology.
[89] A. Zhang,et al. Emerging role and recent applications of metabolomics biomarkers in obesity disease research , 2017 .
[90] M. Schulze,et al. Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Relation to the Risk of Type 2 Diabetes Mellitus: Results From the EPIC-Potsdam Study. , 2016, American journal of epidemiology.
[91] Ross M. Fraser,et al. Genetic studies of body mass index yield new insights for obesity biology , 2015, Nature.
[92] Aung Ko Win,et al. Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer , 2016, British Journal of Cancer.
[93] T. Romacho,et al. Visfatin/Nampt: An Adipokine with Cardiovascular Impact , 2013, Mediators of inflammation.
[94] D. Lawlor,et al. A systematic review of the association between circulating concentrations of C reactive protein and cancer , 2007, Journal of Epidemiology and Community Health.
[95] E. Surmacz,et al. Leptin and cancer , 2006, Journal of cellular physiology.
[96] Tom R. Gaunt,et al. Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis , 2017, Circulation.
[97] Eun-Kyoung Kim,et al. A Metabolomic Approach to Understanding the Metabolic Link between Obesity and Diabetes , 2015, Molecules and cells.
[98] F. Clavel-Chapelon,et al. Serum C‐peptide, IGFBP‐1 and IGFBP‐2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition , 2007, International journal of cancer.
[99] J. Pell,et al. Association of Body Mass Index With Cardiometabolic Disease in the UK Biobank: A Mendelian Randomization Study , 2017, JAMA cardiology.
[100] V. Choo. WHO reassesses appropriate body-mass index for Asian populations , 2002, The Lancet.
[101] Mimi Y. Kim,et al. Insulin-Like Growth Factor Axis and Risk of Type 2 Diabetes in Women , 2012, Diabetes.
[102] Tao Xi,et al. C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis , 2014, Cancer Causes & Control.
[103] Timothy R Church,et al. A taxonomic signature of obesity in a large study of American adults , 2018, Scientific Reports.
[104] J. Reynolds,et al. Obesity, metabolic syndrome and esophageal adenocarcinoma: epidemiology, etiology and new targets. , 2011, Cancer epidemiology.
[105] Jimmy D Bell,et al. Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome. , 2002, The American journal of clinical nutrition.
[106] Obesity, genetic risk, and environment , 2014, BMJ : British Medical Journal.
[107] A. Valsesia,et al. Transcriptome profiling from adipose tissue during a low-calorie diet reveals predictors of weight and glycemic outcomes in obese, nondiabetic subjects. , 2017, The American journal of clinical nutrition.
[108] M. Suárez-Fariñas,et al. Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis. , 2011, The American journal of clinical nutrition.
[109] G. Casey,et al. FTO polymorphisms are associated with adult body mass index (BMI) and colorectal adenomas in African-Americans. , 2011, Carcinogenesis.
[110] R. Wolff,et al. Leptin and colorectal cancer: an undefined link , 2007, Nature Clinical Practice Gastroenterology &Hepatology.
[111] L. Kappelle,et al. Adiponectin and incident coronary heart disease and stroke. A systematic review and meta‐analysis of prospective studies , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[112] E. Rimm,et al. Genetic variation in the ADIPOQ gene, adiponectin concentrations and risk of colorectal cancer: a Mendelian Randomization analysis using data from three large cohort studies , 2017, European Journal of Epidemiology.
[113] Joanna D. Holbrook,et al. Resistin is expressed in human macrophages and directly regulated by PPARγ activators , 2003 .
[114] D. Albanes,et al. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. , 2005, JAMA.
[115] Sung-Ae Jung,et al. Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation. , 2010, Molecular endocrinology.
[116] M. Zhu,et al. Meta‐analysis: Circulating adiponectin levels and risk of colorectal cancer and adenoma , 2011, Journal of digestive diseases.
[117] François G. Meyer,et al. Insulin-like Growth Factors, Their Binding Proteins, and Prostate Cancer Risk: Analysis of Individual Patient Data from 12 Prospective Studies , 2008, Annals of Internal Medicine.
[118] N. Habermann,et al. Gene Expression Changes in Adipose Tissue with Diet- and/or Exercise-Induced Weight Loss , 2013, Cancer Prevention Research.
[119] C. Friedenreich,et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). , 2006, Journal of the National Cancer Institute.
[120] Yuansi Chen,et al. Anthropometric indices as surrogates for estimating abdominal visceral and subcutaneous adipose tissue: A meta-analysis with 16,129 participants. , 2018, Diabetes research and clinical practice.
[121] R. Henry,et al. Adiponectin: more than just another fat cell hormone? , 2003, Diabetes care.
[122] A. Peters,et al. Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach , 2013, Diabetes.
[123] S. Delorme,et al. Validation of Anthropometric Indices of Adiposity against Whole-Body Magnetic Resonance Imaging – A Study within the German European Prospective Investigation into Cancer and Nutrition (EPIC) Cohorts , 2014, PloS one.
[124] A. Astrup,et al. Obesity : Preventing and managing the global epidemic , 2000 .
[125] H. Rosenberg,et al. Cytokine Diversity in Human Peripheral Blood Eosinophils: Profound Variability of IL-16 , 2019, The Journal of Immunology.
[126] H. Kwon,et al. Adipokines Mediate Inflammation and Insulin Resistance , 2013, Front. Endocrinol..
[127] Diana Wald,et al. Automatic quantification of subcutaneous and visceral adipose tissue from whole‐body magnetic resonance images suitable for large cohort studies , 2012, Journal of magnetic resonance imaging : JMRI.
[128] Inês Barroso,et al. The genetics of obesity: FTO leads the way , 2010, Trends in genetics : TIG.
[129] F. Clavel-Chapelon,et al. Total and high-molecular weight adiponectin and risk of colorectal cancer: the European Prospective Investigation into Cancer and Nutrition Study. , 2012, Carcinogenesis.
[130] Tran Quoc Bao,et al. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants , 2016, The Lancet.
[131] G. Norata,et al. Plasma resistin levels correlate with determinants of the metabolic syndrome. , 2007, European journal of endocrinology.
[132] Andrew W Roddam,et al. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies , 2010, The Lancet. Oncology.
[133] B. Henderson,et al. Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[134] Stacey A. Kenfield,et al. Plasma insulin‐like growth factor 1 is positively associated with low‐grade prostate cancer in the Health Professionals Follow‐up Study 1993–2004 , 2011, International journal of cancer.
[135] E. Giovannucci. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. , 2001, The Journal of nutrition.
[136] S. Ebrahim,et al. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.
[137] R. Ross. Advances in the application of imaging methods in applied and clinical physiology , 2003, Acta Diabetologica.
[138] G. Reaven. Insulin resistance: the link between obesity and cardiovascular disease. , 2011, The Medical clinics of North America.
[139] W. Kim,et al. Association between obesity-related adipokines and colorectal cancer: a case-control study and meta-analysis. , 2014, World journal of gastroenterology.
[140] W. Rathmann,et al. Association of longitudinal risk profile trajectory clusters with adipose tissue depots measured by magnetic resonance imaging , 2019, Scientific Reports.
[141] C. Gardner,et al. A systematic review of studies of DNA methylation in the context of a weight loss intervention. , 2017, Epigenomics.
[142] Shigeru Okada,et al. A proteomic approach to obesity and type 2 diabetes , 2015, Journal of cellular and molecular medicine.
[143] C. Newgard,et al. Metabolomics and Metabolic Diseases: Where Do We Stand? , 2017, Cell metabolism.
[144] R. Kaaks,et al. Energy balance and cancer: the role of insulin and insulin-like growth factor-I , 2001, The Proceedings of the Nutrition Society.
[145] M. Beckmann,et al. Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer , 2016, Cancer Epidemiology, Biomarkers & Prevention.
[146] W. Pan,et al. How to define obesity? Evidence-based multiple action points for public awareness, screening, and treatment: an extension of Asian-Pacific recommendations. , 2008, Asia Pacific journal of clinical nutrition.
[147] Tom R. Gaunt,et al. The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium , 2015, Cancer Causes & Control.
[148] P. Delafontaine,et al. Interaction between insulin-like growth factor-1 and atherosclerosis and vascular aging. , 2014, Frontiers of hormone research.
[149] A. Rogol,et al. Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose. , 2005, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[150] C. Kusminski,et al. Role of resistin in obesity, insulin resistance and Type II diabetes. , 2005, Clinical science.